Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
496,218
-
Share change
-
+30,812
-
Total reported value
-
$2,606,000
-
Price per share
-
$5.33
-
Number of holders
-
11
-
Value change
-
+$130,259
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q4 2017
As of 31 Dec 2017,
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
496,218 shares.
The largest 10 holders included
Ibex Investors LLC, RENAISSANCE TECHNOLOGIES LLC, DEUTSCHE BANK AG\, Vantage Investment Advisors, LLC, HighTower Advisors, LLC, Psagot Investment House Ltd., Edge Wealth Management LLC, LADENBURG THALMANN FINANCIAL SERVICES INC., MORGAN STANLEY, and WELLS FARGO & COMPANY/MN.
This page lists
11
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.